[The clinico-immunological efficacy of the new drug preparation Erbisol in patients with chronic hepatitis].
This report presents results of clinicoimmunological evaluation of 52 patients with chronic hepatites, receiving treatment with <<ERBISOL>>. The data obtained suggest high effectiveness of the preparation in the chronic hepatitis patients not only as a hepatoprotective agent but also as an immunomodulating one exerting effect on both the specific and unspecific links of immunity.